URS
RPRX icon

Utah Retirement Systems’s Royalty Pharma RPRX Stock Holding History

Utah Retirement Systems’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.52M Sell
62,812
-134
-0.2% -$6.97K 0.03% 412
2026
Q1 		$3.02M Sell
62,946
-217
-0.3% -$9.5K 0.03% 450
2025
Q4 		$2.44M Buy
63,163
+572
+0.9% +$21.8K 0.02% 518
2025
Q3 		$2.21M Sell
62,591
-1,671
-3% -$60.5K 0.02% 544
2025
Q2 		$2.32M Hold
64,262
– – 0.02% 519
2025
Q1 		$2M Sell
64,262
-338
-0.5% -$10.7K 0.02% 548
2024
Q4 		$1.65M Hold
64,600
– – 0.02% 605
2024
Q3 		$1.83M Hold
64,600
– – 0.02% 586
2024
Q2 		$1.7M Buy
64,600
+500
+0.8% +$13.9K 0.02% 584
2024
Q1 		$1.95M Sell
64,100
-100
-0.2% -$2.95K 0.02% 571
2023
Q4 		$1.8M Buy
64,200
+400
+0.6% +$11K 0.02% 575
2023
Q3 		$1.73M Buy
63,800
+200
+0.3% +$5.94K 0.02% 561
2023
Q2 		$1.96M Sell
63,600
-2,700
-4% -$91.4K 0.03% 535
2023
Q1 		$2.39M Hold
66,300
– – 0.03% 474
2022
Q4 		$2.62M Buy
66,300
+600
+0.9% +$25K 0.04% 411
2022
Q3 		$2.64M Buy
65,700
+200
+0.3% +$8.54K 0.04% 395
2022
Q2 		$2.75M Buy
65,500
+7,500
+13% +$307K 0.04% 398
2022
Q1 		$2.26M Sell
58,000
-1,000
-2% -$39.3K 0.03% 509
2021
Q4 		$2.35M Buy
59,000
+200
+0.3% +$7.77K 0.03% 520
2021
Q3 		$2.13M Sell
58,800
-2,800
-5% -$109K 0.03% 543
2021
Q2 		$2.52M Buy
61,600
+200
+0.3% +$8.51K 0.03% 509
2021
Q1 		$2.68M Buy
61,400
+40,300
+191% +$1.91M 0.04% 467
2020
Q4 		$1.06M Buy
+21,100
New +$895K 0.02% 730

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Utah Retirement Systems's RPRX Position: Q2 2026 in Review

Utah Retirement Systems reduced its Royalty Pharma (RPRX) stake by 0.21% in Q2 2026, selling an estimated $6.97K and leaving 62,812 shares worth $3.52M. The position accounts for 0.03% of the portfolio, ranked #412.

Utah Retirement Systems first reported a position in RPRX in Q4 2020 and has held it in 23 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Utah Retirement Systems held 62,812 shares of Royalty Pharma worth $3.52M as of Q2 2026.
  • Utah Retirement Systems sold 134 Royalty Pharma shares in Q2 2026, an estimated $6.97K.
  • Royalty Pharma made up 0.03% of Utah Retirement Systems's portfolio in Q2 2026, its #412 holding.
  • Utah Retirement Systems first reported a position in Royalty Pharma in Q4 2020 and has held it in 23 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Utah Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.